Iotalamic acid
(Redirected from Iothalamate)
Clinical data | |
---|---|
Trade names | Conray, Glofil-125, Cysto-Conray II, others |
Other names | MI-216, iothalamate meglumine, Iothalamic acid (USAN US) |
AHFS/Drugs.com | Consumer Drug Information |
License data |
|
Routes of administration | Intravascular[1] |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.017.181 |
Chemical and physical data | |
Formula | C11H9I3N2O4 |
Molar mass | 613.916 g·mol−1 |
3D model (JSmol) | |
| |
|
Iotalamic acid, sold under the brand name Conray, is an iodine-containing radiocontrast agent. It is available in form of its salts, sodium iotalamate and meglumine iotalamate. It can be given intravenously or intravesically (into the urinary bladder).[1]
A radioactive formulation is also available as sodium iothalamate I-125 injection (brand name Glofil-125). It is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of people with kidney disease.[2]
References
- ^ a b c "Conray- iothalamate meglumine injection". DailyMed. 1 January 2021. Retrieved 23 February 2022.
- ^ a b "Glofil-125- sodium iothalamate i-125 injection injection, solution". DailyMed. 9 December 2019. Retrieved 23 February 2022.
- ^ "Cysto-Conray II- iothalamate meglumine injection". DailyMed. 31 December 2020. Retrieved 23 February 2022.
External links
- "Iothalamate meglumine". Drug Information Portal. U.S. National Library of Medicine.
- "Iothalamate sodium". Drug Information Portal. U.S. National Library of Medicine.
See what we do next...
OR
By submitting your email or phone number, you're giving mschf permission to send you email and/or recurring marketing texts. Data rates may apply. Text stop to cancel, help for help.
Success: You're subscribed now !